The effect of Lisinopril on blood glucose level given alone and in combination with oral anti-diabetic drugs in alloxan-induced diabetic rats
Neeraj Agrawal, Uma Gupta
Abstract
Neeraj Agrawal, Uma Gupta
Abstract
Background: In diabetic patients, ACE (Angiotensin converting enzyme) inhibitors prevent the development and progression of incipient or established nephropathy and delay the progression of diabetic retinopathy hence these drugs are routinely prescribed with oral anti-diabetic drugs in these conditions. The picture of actual impact of ACE inhibitors on blood glucose is controversial and still not clear. This study therefore aimed to evaluate the effect of Lisinopril on blood glucose level and the interaction with the oral anti-diabetic drugs metformin, gliclazide and pioglitazone in alloxan induced diabetic rats.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Background: In diabetic patients, ACE (Angiotensin converting enzyme) inhibitors prevent the development and progression of incipient or established nephropathy and delay the progression of diabetic retinopathy hence these drugs are routinely prescribed with oral anti-diabetic drugs in these conditions. The picture of actual impact of ACE inhibitors on blood glucose is controversial and still not clear. This study therefore aimed to evaluate the effect of Lisinopril on blood glucose level and the interaction with the oral anti-diabetic drugs metformin, gliclazide and pioglitazone in alloxan induced diabetic rats.
Key concepts: Lisinopril, Medicine, Alloxan, Gliclazide, Metformin, Diabetes mellitus, Diabetic nephropathy, Pharmacology